In addition, co-expression of survivin and vascular endothelial growth factor (VEGF), a highly specific vascular endothelial cell mitogen that promotes angiogenesis in tumor tissue, has recently been found to be associated with recurrence-free progression and overall survival in endometrial cancer patients (55, 56, 57). Here, VEGFA is linked to endometrial cancer.